These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

303 related items for PubMed ID: 8222188

  • 21. Neutralization of enoxaparine-induced bleeding by protamine sulfate.
    Van Ryn-McKenna J, Cai L, Ofosu FA, Hirsh J, Buchanan MR.
    Thromb Haemost; 1990 Apr 12; 63(2):271-4. PubMed ID: 2163553
    [Abstract] [Full Text] [Related]

  • 22. Recombinant human antithrombin III restores heparin responsiveness and decreases activation of coagulation in heparin-resistant patients during cardiopulmonary bypass.
    Avidan MS, Levy JH, van Aken H, Feneck RO, Latimer RD, Ott E, Martin E, Birnbaum DE, Bonfiglio LJ, Kajdasz DK, Despotis GJ.
    J Thorac Cardiovasc Surg; 2005 Jul 12; 130(1):107-13. PubMed ID: 15999048
    [Abstract] [Full Text] [Related]

  • 23. The influence of preoperative anticoagulation on heparin response during cardiopulmonary bypass.
    Dietrich W, Spannagl M, Schramm W, Vogt W, Barankay A, Richter JA.
    J Thorac Cardiovasc Surg; 1991 Oct 12; 102(4):505-14. PubMed ID: 1833592
    [Abstract] [Full Text] [Related]

  • 24. Studies on the neutralizing effects of protamine on unfractionated and low molecular weight heparin (Fragmin) at the site of activation of the coagulation system in man.
    Wolzt M, Weltermann A, Nieszpaur-Los M, Schneider B, Fassolt A, Lechner K, Eichler HG, Kyrle PA.
    Thromb Haemost; 1995 Mar 12; 73(3):439-43. PubMed ID: 7667826
    [Abstract] [Full Text] [Related]

  • 25. Efficacy of a heparin removal device in comparison with protamine after hypothermic cardiopulmonary bypass.
    Tao W, Deyo DJ, Brunston RL, Vertrees RA, Grochoske TL, Zwischenberger JB.
    ASAIO J; 1997 Mar 12; 43(5):M825-30. PubMed ID: 9360162
    [Abstract] [Full Text] [Related]

  • 26. In vitro effect of fresh frozen plasma on the activated coagulation time in patients undergoing cardiopulmonary bypass.
    Barnette RE, Shupak RC, Pontius J, Rao AK.
    Anesth Analg; 1988 Jan 12; 67(1):57-60. PubMed ID: 3257361
    [Abstract] [Full Text] [Related]

  • 27. Rate of protamine administration: its effect on heparin reversal and antithrombin recovery after coronary artery surgery.
    Zaidan JR, Johnson S, Brynes R, Monroe S, Guffin AV.
    Anesth Analg; 1986 Apr 12; 65(4):377-80. PubMed ID: 3954111
    [Abstract] [Full Text] [Related]

  • 28. Heparin rebound phenomenon--much ado about nothing?
    Martin P, Horkay F, Gupta NK, Gebitekin C, Walker DR.
    Blood Coagul Fibrinolysis; 1992 Apr 12; 3(2):187-91. PubMed ID: 1606290
    [Abstract] [Full Text] [Related]

  • 29. The pharmacological profile of the low molecular weight heparin 21-23 in man: anticoagulant, lipolytic and protamine reversible effects.
    Harenberg J, Stehle G, Dempfle CE, von Hodenberg E, Heene DL.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989 Apr 12; 116(6):967-80. PubMed ID: 2483715
    [Abstract] [Full Text] [Related]

  • 30. Monitoring of intraoperative heparinization and blood loss following cardiopulmonary bypass surgery.
    Babka R, Colby C, El-Etr A, Pifarré R.
    J Thorac Cardiovasc Surg; 1977 May 12; 73(5):780-2. PubMed ID: 850438
    [Abstract] [Full Text] [Related]

  • 31. A comparison of activated coagulation time-based techniques for anticoagulation during cardiac surgery with cardiopulmonary bypass.
    Slight RD, Buell R, Nzewi OC, McClelland DB, Mankad PS.
    J Cardiothorac Vasc Anesth; 2008 Feb 12; 22(1):47-52. PubMed ID: 18249330
    [Abstract] [Full Text] [Related]

  • 32. Relationships between antithrombin activity, anticoagulant efficacy of heparin therapy and perioperative variables in patients undergoing cardiac surgery requiring cardiopulmonary bypass.
    Muedra V, Bonanad S, Gómez M, Villalonga V, Sánchez F, Llopis JE.
    Perfusion; 2011 Nov 12; 26(6):487-95. PubMed ID: 21665912
    [Abstract] [Full Text] [Related]

  • 33. Protamine neutralization of the release of tissue factor pathway inhibitor activity by heparins.
    Harenberg J, Siegele M, Dempfle CE, Stehle G, Heene DL.
    Thromb Haemost; 1993 Dec 20; 70(6):942-5. PubMed ID: 8165616
    [Abstract] [Full Text] [Related]

  • 34. Heparin monitoring during cardiopulmonary bypass.
    Saleem A, Shenaq SS, Yawn DH, Harshberger K, Diemunsch P, Mohindra P.
    Ann Clin Lab Sci; 1984 Dec 20; 14(6):474-9. PubMed ID: 6508227
    [Abstract] [Full Text] [Related]

  • 35. Heparin and Protamine Titration Does Not Improve Haemostasis after Cardiac Surgery: A Prospective Randomized Study.
    Radulovic V, Laffin A, Hansson KM, Backlund E, Baghaei F, Jeppsson A.
    PLoS One; 2015 Dec 20; 10(7):e0130271. PubMed ID: 26134993
    [Abstract] [Full Text] [Related]

  • 36. Challenges with heparin-based anticoagulation during cardiopulmonary bypass in children: Impact of low antithrombin activity.
    Manlhiot C, Gruenwald CE, Holtby HM, Brandão LR, Chan AK, Van Arsdell GS, McCrindle BW.
    J Thorac Cardiovasc Surg; 2016 Feb 20; 151(2):444-50. PubMed ID: 26553458
    [Abstract] [Full Text] [Related]

  • 37. Monitoring incomplete heparin reversal and heparin rebound after cardiac surgery.
    Galeone A, Rotunno C, Guida P, Bisceglie A, Rubino G, Schinosa Lde L, Paparella D.
    J Cardiothorac Vasc Anesth; 2013 Oct 20; 27(5):853-8. PubMed ID: 23627997
    [Abstract] [Full Text] [Related]

  • 38. Subtle differences in commercial heparins can have serious consequences for cardiopulmonary bypass patients: A randomized controlled trial.
    Arsenault KA, Paikin JS, Hirsh J, Dale B, Whitlock RP, Teoh K, Young E, Ginsberg JS, Weitz JI, Eikelboom JW.
    J Thorac Cardiovasc Surg; 2012 Oct 20; 144(4):944-950.e3. PubMed ID: 22743176
    [Abstract] [Full Text] [Related]

  • 39. A case series of recombinant platelet factor 4 for heparin reversal after cardiopulmonary bypass.
    Demma L, Levy JH.
    Anesth Analg; 2012 Dec 20; 115(6):1273-8. PubMed ID: 22859690
    [Abstract] [Full Text] [Related]

  • 40. Protamine requirements in cardiac surgery: effect of changes in the heparin reference standard.
    Taneja R, Berry L, Pappu U, Stitt L, Sayal P, Allen P, Hoogendoorn H, Chan A.
    J Cardiothorac Vasc Anesth; 2014 Oct 20; 28(5):1227-32. PubMed ID: 25281041
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.